Results 111 to 120 of about 1,282 (170)
El tratamiento actualmente recomendado para la Leishmaniasis visceral por L. infantum es Anfotericina B liposomal (ABL), a una dosis de 4 mg/kg durante 5 días consecutivos y una dosis de recuerdo al décimo día. Este tratamiento presenta baja toxicidad, alta eficacia y costes más bajos en comparación con otros fármacos debido a estancias hospitalarias ...
Olbrich, Peter +4 more
openaire +2 more sources
Sepsis-like histoplasmosis in a kidney transplant patient. [PDF]
Fernandes AR +6 more
europepmc +1 more source
Visceral leishmaniasis in kidney transplant recipients and candidates: an integrative review of the last 20 years. [PDF]
Viana Neto OM +10 more
europepmc +1 more source
In recent years, great advances have been produced in the treatment of invasive pulmonary aspergillosis. However, current treatment recommendations still show suboptimal rates of success underlining the need for better therapies. A possible new strategy adressed to increase therapeutic success might be based on new ways to administer currently ...
openaire +1 more source
[Community outbreak of leishmaniasis in the southern area of the community of Madrid]. [PDF]
Noguerol Álvarez M +3 more
europepmc +1 more source
Resolution of cutaneous leishmaniasis after acute eczema due to intralesional meglumine antimoniate. [PDF]
Ferreira e Vasconcellos Ede C +4 more
europepmc +1 more source
LXII Congreso Nacional de la SEHH, XXXVI Congreso Nacional de la SETH Virtual, 26-30 de octubre, 2020. [PDF]
The Authors.
europepmc +1 more source
Continuous infusion of amphotericin B: preliminary experience at Faculdade de Medicina da Fundação ABC. [PDF]
Uehara RP +7 more
europepmc +1 more source
[Infection in lung transplantation]. [PDF]
Gavaldà J, Román A.
europepmc +1 more source

